



Enrofar Injection
New Products From This Supplier
Composition: Each ml contains: Enrofloxacin 100mg ENROFAR injection is indicated in Haemorrhagic Septicemia, Matitis, Enteritis, Metritis, Urinary and Genital Injections, Cystisis and Urethritis. ENROFAR Injection is effective against respiratory tract infections, pneumonia, bronchitis, joint-ill, navel-ill, Alimentary tract infections and wound infections. ENROFAR injection is also indicated to be used against mycoplasma, E-Coli, Clostridia, Pseudomonas and Streptococcus. ENROFAR injection effectively controls fowl cholera, fowl typhoid, omphalitis, air sacultis and colisepticemia.
Dosage & Administration:
Pharmacological Dose is administered at a dose of 2.5 mg / kg bodyweight / day via subcutaneous or intramuscular route in cattle, swine and sheep. It is administered at a dose of 2.5 - 5 mg / kg bodyweight /day in camels.
Practical dose: is 2.5 ml / 100 kg bodyweight.
Presentation: 50ml, 100 ml vials.
Business Nature
Manufacturer
Year Established
2014
Country/Region
Lahore, Pakistan
Main Products
Veterinary Medicine...
Payment Terms
Letter of Credit (L/C), Bank wire (T/T)
Izfaar Pharmaceuticals (Pvt.) Limited is an ISO 9001:2008 Certified manufacturer of drugs and medicines for veterinary, and poultry use. Izfaar Pharmaceuticals (Pvt.) Ltd, was established in 2014 and licensed by the Ministry of Health, Government of Pakistan. All the products are registered and confirm to respective G.M.P. requirements.